Drug Class Comparison Charts

[2] which topical corticosteroid to recommend (1/18)
[3] Reps will promote Fiasp (FEE-asp, insulin aspart) as an "ultrafast-acting" mealtime insulin for adults (12/17)
[4] whether it's okay for patients to switch antiplatelet meds after a coronary stent (11/17)
[5] Duzallo (doo-ZAL-oh) will be a new chronic gout med that combines lesinurad with allopurinol (11/17)
[6] which beta-blocker to recommend and how to switch (10/17)
[7] how to manage patients who have a BREAKTHROUGH ischemic stroke while taking aspirin (10/17)
[8] whether insulin degludec (Tresiba, etc) is better than other basal insulins (Lantus, etc) for type 2 diabetes (9/17)
[9] A new boxed warning about amputation with canagliflozin (Invokana, etc) will have patients asking about the safety of SGLT2 inhibitors (7/17)
[0] differences among oral iron supplements (3/17)
[-] new Eucrisa (you-KRIS-ah, crisaborole) ointment will raise questions about how to manage eczema (2/17)
[-] confusion with two new OTC fluticasone nasal sprays, Flonase Sensimist and ClariSpray (2/17)
[-] Differin 0.1% (adapalene) GEL will be the first Rx topical retinoid to go OTC (1/17)
[-] "T" can stand for "trouble" with Tradjenta, Trulicity, Tanzeum, Toujeo, and Tresiba (12/16)
[-] Does the new GoNitro (goh-NYE-troh) have any advantages over other sublingual nitroglycerin products for acute angina (11/16)
[-] how to treat patients with newly diagnosed type 2 diabetes and VERY high blood glucose (10/16)
[-] Many of your atrial fibrillation patients aren't getting appropriate anticoagulation (10/16)
[-] how to optimize therapy for angina (9/16)
[-] New sumatriptan products and warnings about Zecuity will lead to questions about how sumatriptan formulations for migraines compare (8/16)
[-] It can be confusing to sort through the long-acting calcium channel blockers (7/16)
[-] confusion about concentrated insulins (7/16)
[-] New warnings will link aripiprazole (Abilify, etc) to a higher risk of impulse-control behaviors (6/16)
[-] how to treat type 2 diabetes in heart failure patients (6/16)
[-] generic rosuvastatin (Crestor, etc) (6/16)
[-] question the role of aliskiren (Tekturna) (6/16)
[-] how to pick an oral potassium chloride product (4/16)
[-] new stimulant products for ADHD (3/16)
[-] More warnings for the SGLT2 inhibitors (Invokana, etc) will increase concerns about their safety (2/16)
[-] falls and fractures in BPH patients taking SELECTIVE alpha-blockers (tamsulosin, etc) (2/16)
[-] Tresiba (treh-SEE-bah, insulin degludec) is a new once-daily ULTRA long-acting insulin (1/16)
[-] aripiprazole (Abilify, etc) is associated with a higher risk of certain impulse-control behaviors (1/16)
[-] Invega Trinza (in-VAY-guh TRIN-zuh, paliperidone) will raise questions about long-acting injectable atypical antipsychotics (9/15)
[-] With new Abilify (aripiprazole) generics, you'll have more opportunity to rein in inappropriate use of atypical antipsychotics (7/15)
[-] when to recommend an intrauterine device (IUD) for contraception (7/15)
[-] individualizing metformin add-ons in patients with type 2 diabetes (6/15)
[-] Patients being discharged on sleep meds are raising concerns (5/15)
[-] consensus on using statins for diabetes patients (4/15)
[-] Ferric pyrophosphate (Triferic) will be a new option to maintain iron levels in hemodialysis patients (4/15)
[-] Afrezza (uh-FREZ-uh) will be a new INHALED insulin for diabetes (3/15)
[-] Savaysa (sa-VAYE-sah, edoxaban) will be the fourth new oral anticoagulant (3/15)
[-] Saxenda (sax-END-ah) will be the first GLP-1 agonist for obesity (2/15)
[-] how pharmacists can improve the care of asthma patients (12/14)
[-] two new ORAL hepatitis C regimens...Harvoni (har-VOE-nee) and Olysio (simeprevir) PLUS Sovaldi (sofosbuvir) (12/14)
[-] using NON-opioids to manage short-term pain now that hydrocodone combos (Vicodin, etc) are Schedule II (11/14)
[-] A "stratified" approach will optimize acute migraine treatment (11/14)
[-] two new antiepileptic drugs called Fycompa (fye-COM-puh) and Aptiom (AP-tee-om) (11/14)
[-] Contrave (CON-trave) will compete with Belviq (lorcaserin) and Qsymia (phentermine/topiramate ER) for weight loss (11/14)
[-] Jardiance (jar-DEE-ans, empagliflozin) will be the third SGLT2 inhibitor (10/14)
[-] how long aspirin PLUS another antiplatelet drug should be used after a coronary stent (10/14)
[-] Patients will ask if they should stop niacin (Niaspan, etc) (9/14)
[-] how to manage hypokalemia in patients on diuretics (hydrochlorothiazide, furosemide, etc) (9/14)
[-] Tanzeum (TAN-zee-um, albiglutide) will be another GLP-1 agonist for diabetes (8/14)
[-] three new antiepileptic drugs called Qudexy XR (cue-DEKS-ee), Fycompa (fi-COM-puh), and Aptiom (AP-tee-om) (8/14)
[-] how to use the new cholesterol guidelines in "real world" patients (7/14)
[-] more emphasis on improving colon cancer screening (3/14)
[-] skyrocketing costs of GENERIC drugs (3/14)
[-] more lipid drugs get indications based on HARD clinical outcomes (12/13)
[-] two new antidepressants, Brintellix (brin-TEL-ix, vortioxetine) and Fetzima (fet-ZEE-muh, levomilnacipran) (12/13)
[-] More patients who are allergic to penicillin will get a cephalosporin for common respiratory tract infections (10/13)
[-] new FOUR-phase extended-cycle oral contraceptive, Quartette (kwor-TET, levonorgestrel/ethinyl estradiol) (9/13)
[-] new warnings about olmesartan (Benicar, etc) and serious GI problems (9/13)
[-] more debate about using antithrombotics to prevent strokes in elderly patients with atrial fibrillation (8/13)
[-] new ezetimibe and statin combo for dyslipidemia called Liptruzet (LIP-true-zet) (7/13)
[-] how to manage stimulant side effects in kids and teens with ADHD (3/13)
[-] approval of Eliquis (ELL-eh-kwiss, apixaban) will intensify the marketing war among the NEW oral anticoagulants (2/13)
[-] Niacin will continue to fall out of favor for dyslipidemia (2/13)
[-] three more pancrelipase products, Ultresa (ul-TRES-a), Viokace (VYE-oh-kase), and Pertzye (PERT-zye) (1/13)
[-] Beta-blockers will continue to fall out of favor for hypertension (1/13)
[-] Xarelto (rivaroxaban) will be used to TREAT venous thromboembolism (12/12)
[-] bigger push to limit NSAIDs in heart attack patients INDEFINITELY (11/12)
[-] About 25% of your patients over age 65 have type 2 diabetes (11/12)
[-] whether it makes sense to use more than one antipsychotic for schizophrenia (10/12)
[-] supplies of the direct thrombin inhibitor lepirudin (Refludan) dwindle over the next few months (8/12)
-- Comparison of Injectable Anticoagulants
[-] take both a GLP-1 agonist (Byetta, etc) and DPP-4 inhibitor (Januvia, etc) for type 2 diabetes (8/12)
-- Combining a GLP-1 Agonist and a DPP-4 Inhibitor for Type 2 Diabetes
[-] Keeping track of the different spectrums of the IV and oral cephalosporins can be a real challenge (7/12)
-- Comparison of Cephalosporins
[-] When to use an ORAL cephalosporin and which one (7/12)
-- Comparison of Cephalosporins
[-] more guidance on what to use to prevent migraine (7/12)
-- Strategies for Preventing Migraine Headaches
[-] a more "patient-centered" approach for choosing meds to add to metformin for type 2 diabetes (6/12)
-- Choosing Diabetes Meds to Add to Metformin
[-] Gelnique 3% for overactive bladder (5/12)
[-] Statin patients will get fewer liver function tests (5/12)
-- When to Monitor Liver Enzymes for Patients Taking Statins
[-] Brilinta (ticagrelor) for acute coronary syndrome (5/12)
-- Which Antiplatelet Drug to Add to Aspirin for Acute Coronary Syndrome
[-] more generic ARBs in 2012 (3/12)
-- New Generic ARBs
[-] Bydureon (by-DUR-ee-on), a new long-acting form of Byetta (exenatide) for type 2 diabetes (3/12)
-- New Once WEEKLY Exenatide (Bydureon)
[-] whether ADHD stimulants increase cardiovascular risk or substance abuse in ADULTS (2/12)
-- Adults with ADHD: Cardiovascular Risk and Substance Abuse Considerations
[-] Carisoprodol (Soma, etc) will finally be a Schedule IV controlled substance in ALL states (1/12)
-- Carisoprodol: Schedule IV Controlled Substance Nationwide
[-] comparisons between warfarin, dabigatran (Pradaxa), and rivaroxaban (Xarelto) (12/11)
-- Warfarin vs Pradaxa or Xarelto for Atrial Fib
[-] you'll see even more off-label use of atypical antipsychotics (12/11)
-- Off-Label Use of Atypical Antipsychotics in Adults
[-] new strengths of AndroGel and Androderm (testosterone) (12/11)
-- Comparison of Testosterone Products
[-] You'll see a big shift in statin use when atorvastatin (Lipitor) goes generic at the end of November (11/11)
-- Shift in Statin Use with Generic Atorvastatin
[-] controversy over which ORAL anticoagulant to use to prevent strokes in patients with atrial fibrillation (10/11)
-- Oral Anticoagulants
[-] confusing the news about Avandia and Actos (7/11)
-- Actos (Pioglitazone) and Increased Risk of Bladder Cancer
[-] Singulair is "as good as" inhaled corticosteroids or long-acting beta-agonists for asthma (7/11)
-- Leukotriene Antagonists: A New Role in Asthma?
-- Patient Education Handout
[-] HIGHER blood pressure goals in some elderly patients (6/11)
-- Hypertension in the Elderly: Pharmacotherapy Focus
-- Patient Education Handout
[-] more emphasis on the treatment of bipolar disorder (6/11)
-- Pharmacotherapy of Bipolar Disorder in Adults
[-] Tradjenta (TRAD-gen-ta), a new gliptin for type 2 diabetes (6/11)
-- New Drug: Tradjenta (Linagliptin)
[-] testosterone replacement therapy (3/11)
-- Comparison of Testosterone Products
[-] approval of Amturnide means you'll get more questions about when to use TRIPLE combo products for hypertension (3/11)
[-] what they can use to PREVENT migraines (3/11)
-- Drugs Used to Prevent Migraine Headaches
[-] you'll have more options to help patients get a suitable atypical antipsychotic (2/11)
[-] Cycloset, a new form of bromocriptine for type 2 diabetes (2/11)
-- Cycloset: A New Bromocriptine Formulation for Diabetes
[-] whether it's okay for patients with elevated liver enzymes to take a statin (1/11)
-- Statins and the Liver
[-] whether postmenopausal estrogen plus progestin therapy increases breast cancer risk (12/10)
[-] an ultra low-dose Lo Loestrin Fe and Beyaz with added FOLATE (12/10)
-- Lo Loestrin Fe: A New Ultra-Low Dose Oral Contraceptive
[-] possible link between Actos (pioglitazone) and bladder cancer (10/10)
-- Actos (Pioglitazone) and Risk of Bladder Cancer
[-] controversy over the approval of GENERIC enoxaparin (9/10)
-- Approval of Generic Enoxaparin (Lovenox)
[-] whether angiotensin receptor blockers increase cancer or cardiovascular risk (8/10)
-- Angiotensin Receptor Blockers (ARBs) and Cancer Risk
[-] limit use of PPIs (omeprazole, etc) (7/10)
-- Proton Pump Inhibitors: Appropriate Use and Safety Concerns
-- Patient Education Handout
[-] new oral contraceptive called Natazia (estradiol valerate/dienogest) (7/10)
-- Natazia (Estradiol Valerate and Dienogest)
[-] if hormone therapy increases cancer risk (6/10)
-- Postmenopausal Hormone Therapy and Cancer Risk
[-] new statin called Livalo (LIV-al-o, pitavastatin) (6/10)
-- Characteristics of the Various Statins
[-] which is the best drug to add to metformin for type 2 diabetes (5/10)
-- How to Treat Type 2 Diabetes
[-] concerns about using Protopic (tacrolimus) and Elidel (pimecrolimus) for eczema in kids (5/10)
-- Management of Eczema in Children
[-] There's still debate about when and how to taper oral steroids (5/10)
-- Corticosteroids: Selection, Tapering, and More
[-] whether intensive treatment of blood pressure or lipids is beneficial for type 2 diabetes patients (4/10)
-- Intensive Blood Pressure and Lipid Control for Patients with Diabetes: More from ACCORD
[-] three new ORAL drugs for multiple sclerosis...Ampyra, cladribine, and fingolimod (3/10)
[-] Losartan will be the first GENERIC angiotensin receptor blocker (3/10)
-- Comparison of Angiotensin Receptor Blockers
[-] Victoza (VIC-tow-za) will compete with Byetta for type 2 diabetes (3/10)
-- New Drug: Victoza (Liraglutide)
[-] how to choose a long-acting isosorbide product (3/10)
-- Comparison of Nitrates
[-] the OTC proton pump inhibitors, Prilosec OTC, Prevacid 24HR, and soon Zegerid OTC (2/10)
-- Comparison of Proton Pump Inhibitors
[-] what to use for uncomplicated vaginal yeast infections (2/10)
-- Candidiasis Treatment Guidelines
[-] The Zetia controversy and New Year's resolutions will spark new emphasis on treating lipids (1/10)
-- Second-Line Therapy of Dyslipidemia
-- Patient Education Handout
[-] Sumavel DosePro, a new NEEDLE-FREE sumatriptan injection for migraines (1/10)
-- Comparison of Triptans
[-] how to switch women from oral to topical estrogens (11/09)
-- Converting Between Estrogen Products
[-] Saphris (SA-fris), a new atypical antipsychotic for schizophrenia and bipolar disorder (10/09)
-- Comparison of Atypical Antipsychotics
[-] A growing number of products with probiotics (9/09)
-- Comparison of Common Probiotic Products
-- Patient Education Handout
[-] Lamictal ODT and Lamictal XR tablets add to the confusion of which lamotrigine product to choose (7/09)
-- Choosing the Right Lamotrigine Formulation
[-] new epilepsy drug called Vimpat (lacosamide) (7/09)
-- Comparison of Antiepileptic Drugs
[-] Toviaz (TOE-vee-az) and Gelnique (gel-NEEK) will compete in a crowded market of antimuscarinics for overactive bladder (6/09)
-- Medications for Overactive Bladder
[-] Rapaflo (silodosin), a new selective alpha-blocker for benign prostatic hyperplasia (BPH) (5/09)
-- Comparison of Alpha-Blockers
[-] generic substitution of long-acting calcium channel blockers (Cardizem CD, Tiazac, etc) (5/09)
-- Comparison of Calcium Channel Blockers
[-] which triptan to use for migraines (5/09)
-- Comparison of Triptans
[-] Is chlorthalidone better than hydrochlorothiazide (3/09)
-- Comparison of Commonly Used Diuretics
[-] new proton pump inhibitor called Kapidex (3/09)
-- Comparison of Proton Pump Inhibitors
[-] how Pristiq compares to venlafaxine (Effexor XR, etc) (2/09)
-- Comparison of Venlafaxine and Desvenlafaxine
[-] which bowel prep to use now that most of the OTC sodium phosphate solutions are off the shelves (2/09)
-- Comparison of Bowel Preps
[-] Trilipix (try-LIP-iks) launch is bringing up questions about the appropriate use of fibrates with statins (2/09)
-- Comparison of Fenofibric Acid and Fenofibrate Products
[-] The arrival of Flo-Pred and Veripred 20 will raise more questions about how to select an oral prednisolone product (1/09)
-- Comparison of Oral Prednisolone Formulations
[-] Sancuso patches and Aloxi capsules will be new options for preventing nausea and vomiting due to chemotherapy (11/08)
-- Comparison of Antiemetics
[-] Stavzor adds to the confusion of which valproate product to choose (11/08)
-- Comparison of Divalproex Sodium and Oral Valproic Acid Products
[-] Vitamin K is showing up in more calcium supplements (10/08)
-- Comparison of Oral Calcium Salts
[-] There's confusion about the different oral iron products (8/08)
-- Comparison of Oral Iron Supplements
[-] Chantix should NOT be used by pilots, air traffic controllers, truckers, and bus drivers (7/08)
-- Comparison of Smoking Cessation Drug Therapy
[-] Patients often ask about the right way to use patches (7/08)
-- Characteristics of Transdermal Patches
[-] Patanase (olopatadine) and Omnaris (ciclesonide) nasal sprays for allergic rhinitis (6/08)
-- Nasal Sprays for Allergic Rhinitis
[-] Is it better to use an ACE inhibitor, angiotensin receptor blocker (ARB), or both in patients at risk for heart disease (6/08)
-- ACEI, ARB, and Aliskiren Comparison
[-] You'll soon see ads for a new antidepressant called Pristiq (5/08)
-- Comparison of Antidepressants
[-] topical treatments for chronic wound debridement (5/08)
-- Comparison of Chronic Wound Care Products
[-] Evamist is the first estradiol SPRAY for menopausal symptoms (4/08)
-- Postmenopausal Hormone Therapy
[-] Can kids overdose on amoxicillin (4/08)
-- Comparison of Amoxicillin Products
[-] new beta-blocker called Bystolic (buy-STOL-ic) (2/08)
-- Comparison of Oral Beta-Blockers
[-] OTC products for wound care (12/07)
[-] Doribax (doripenem) is the fourth carbapenem antibiotic (12/07)
-- Comparison of Carbapenem Antibiotics
[-] how to choose the right oral contraceptive (12/07)
-- Hormonal Contraception
[-] what to do if a child's antibiotic is accidentally left out of the refrigerator (11/07)
-- Pediatric Oral Antibiotic and Antifungal Suspensions and Liquids
[-] New NIH guidelines will improve asthma treatment (10/07)
-- National Asthma Guidelines Update 2007
-- Patient Education Handout
[-] What should you put in "magic mouthwash" (7/07)
-- Magic Mouthwash
[-] Patients will be asking about Miralax (polyethylene glycol) now that it's being switched from Rx to OTC (5/07)
-- Medications for Constipation
[-] Zaditor and Alaway are two new OTCs to relieve itchy eyes due to allergic conjunctivitis (1/07)
-- Ophthalmic Medications for Allergic Conjunctivitis
[-] differences between muscle relaxants (12/06)
-- Muscle Relaxants
[-] how to store their injectable diabetes meds (9/06)
-- Comparison of Insulins
[-] reimbursement for Zocor and the new generic simvastatins (8/06)
-- Characteristics of the Various Statins
[-] probiotics for "digestive health" (7/06)
-- Probiotics: An Update
-- Patient Education Handout
[-] prescription topical steroids aren't safe enough for OTC use (3/06)
-- Comparison of Topical Corticosteroids
[-] Avandaryl, a new combination of rosiglitazone and glimepiride (2/06)
-- Oral Combination Products for Type 2 Diabetes
[-] Sparlon and Daytrana, two new drugs for ADHD (2/06)
-- Drug Treatment for Attention Deficit Hyperactivity Disorder
[-] Are the newer atypical antipsychotics (Zyprexa, etc) better than the older agents for schizophrenia (11/05)
-- Role of Atypical Antipsychotics in Treating Patients with Schizophrenia: Are they Better than the Older Agents?
[-] Ambien CR, a new extended-release zolpidem for insomnia (10/05)
-- Comparison of Insomnia Treatments
-- Patient Education Handout
[-] A new quinolone, Factive, is hitting the market (9/04)
-- Summary of Commonly Used Fluoroquinolones

Home  | Login  | Issues  | Feedback  | Search  | New Drugs  | Email Us  | More >

[*]Top | [#]Bottom